The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Evaluating the Response to Treatment in Patients with Multiple Myeloma | Zendy

Carmelo Caldarella | Zendy; Giorgio Treglia | Zendy; Maria Antonietta Isgrò | Zendy; Ivan Treglia | Zendy; Alessandro Giordano | Zendy

Open Access

The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Evaluating the Response to Treatment in Patients with Multiple Myeloma

Author(s) -

Carmelo Caldarella,

Giorgio Treglia,

Maria Antonietta Isgrò,

Ivan Treglia,

Alessandro Giordano

Publication year - 2012

Publication title -

international journal of molecular imaging

Language(s) - English

Resource type - Journals

eISSN - 2090-1712

pISSN - 2090-1720

DOI - 10.1155/2012/175803

Subject(s) - medicine , positron emission tomography , fluorodeoxyglucose , nuclear medicine , multiple myeloma , positron emission tomography computed tomography , pet ct , radiology , pet imaging

Background and Aim . Fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is well recognized as a powerful diagnostic tool in the initial staging of patients with multiple myeloma (MM). The aim of this paper is to perform a systematic review about the usefulness of FDG-PET or PET/CT in evaluating the response to treatment in patients with MM. Methods . The scientific literature about the role of FDG-PET or PET/CT in evaluating the response to treatment in patients affected by MM was systematically reviewed. Results . Ten studies about the role of FDG-PET or PET/CT in evaluating treatment response in MM were retrieved and discussed. Conclusions . FDG-PET or PET/CT seems to be helpful in assessing the response to treatment in patients with MM and in the evaluation of possible sites of recurrent or progressive disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research